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Abstract: Stem cells represent a great hope for regenerative medicine. In adult life, stem cell deposits are kept in
organ niches; the need for tissue or organ regeneration mobilizes stem cells via the SDF-1-CXCR4 regulation axis.
Constant regeneration of the skin is achieved due to stem cell differentiation within the epidermis and the hair
follicle; thus, skin may serve as an excellent source of stem cells. This is of paramount importance in the treatment
of chronic skin wounds and burns. (Folia Histochemica et Cytobiologica 2011; Vol. 49, No. 3, pp. 375–380)
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Introduction
The great interest in the biology of stem cells (SC) is
related to their capacity for self-renewal, replication
and differentiation to other cells that build different
tissues and organs. SCs replenish lost cells through-
out an organism’s lifespan. SCs have the capacity for
unlimited replication that gives a population of ‘sis-
ter’ SCs. These cells are responsible for self-renewal
and differentiate into tissue-specific cells. This pro-
cess maintains the constant number of aging somatic
cells, which become apoptotic. In the future, SCs
could be used in the treatment and regeneration of
organs and tissues. The implantation of SCs could be
applied instead of the transplantation of tissue and
organs. This would be a huge step in regenerative
medicine [1–6].
There are several types of SCs, which differ one
from another in their proliferation and differentia-
tion capacity. The less mature SCs have greater pos-
sibilities of differentiation and replication. Previous
research suggested that tissue-commited stem cells
(TCSCs) showed plasticity i.e. the possibility of these
cells transdifferentiating into other TCSCs under the
control of environmental factors. For example, he-
matopoietic stem cells (HSCs) could differentiate into
heart stem cells, hepatic stem cells or pancreas stem
cells. The new hypothesis on this subject is that stem
cell niches are not only colonized by TCSCs but also
contain pluripotent stem cells (PSCs), which can dif-
ferentiate into specific tissue [7, 8].
PSCs express embryonic markers such as Oct4,
Nanong and Rex-1 and give rise to SCs specific for
various tissues and organs; some of them are depos-
ited during embryogenesis in organs and can survive
in these localizations to adulthood [9–15].
Kucia and Ratajczak [16, 17] confirmed that bone
marrow (BM) and other tissue of adults is equipped
with PSCs — the very small embryonic-like stem cells
(VSELs). The morphology of these cells and their
immunohistochemical features are similar to those
of early embryonic SCs. They were initially isolated
from murine BM as a homogenic lineage Sca-1+lin-
-CD45– which demonstrates coexpression of PSCs
markers such as SSEA-1, Oct-4, Nanog and Rex-1
[18]. Direct electron microscopy showed cells with
a large nucleus with euchromatin and narrow cyto-
plasm. The cells are isolated from human BM, circu-
lating blood and umbilical cord blood as
CD34+CD133+CXCR4+lin-CD45–, small size cells
(7 μm in diameter ) [19–21]. In vitro, they differentiate
into all three germ layers [16]. These cells are enriched
for mRNA for skin epidermis like Trp63, Krt2-5, BNC
[16]. During ontogenesis, VSELs are deposited in BM
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and in other organs (tissues) and are mobilized in
cases of organ and tissue damage for their regenera-
tion [22, 23]. Their number is higher in young indi-
viduals and decreases with age [7, 16].
The stem cells migration, which is the key process
in their development and regeneration, is regulated
by the axis CXCR4-SDF-1 [24–26]. CXCR4 receptor
has been described in many types of tissue-specific
SCs including nervous tissue, skeletal muscles, heart,
liver, endothelium, tubules of nephron, pigment cells
of retina and embryonic PSC. SCs follow the SDF-1
gradient. The SDF-1 is expressed in stromal, endot-
helial, cardiac, skeletal muscle, liver, brain and renal
cells. Recently, the alternative receptor for SDF-1,
CXCR7, was described [26, 27]. The damage of tis-
sue increases expression of SDF-1 that attracts
CXCR4+ SCs, which are necessary for organ repara-
tion. The expression of SDF-1 can be up-regulated
by HIF-1a and down-regulated by steroids, granulo-
cytes colony stimulating factor (G-CSF) and trans-
forming growth factor (TGF-b1) [25].
Investigators have found SCs in the niches of the
epidermis [9, 10, 13]. PSCs as Oct4+ embryonic cells
or as non-epidermal non-melanocyte Oct4+Nanog+
cells have been identified in the same niche [28]. The
association of these cells with VSELs requires fur-
ther investigation.
Dyce et al. [29] determined that SCs isolated from
the skin include a population capable of differentiat-
ing into oocyte-like cells expressing Oct4 and other
markers characteristic for oocytes. The hypothesis on
the migration of cells of epiblast — primordial germ
cells (PGCs) — into nongonadal niches during early
embryogenesis may explain their presence in the skin.
Obtaining PSCs from the skin may potentially give
us new uses for these cells in terms of treatment, and
become a new experimental model for in vitro studies.
Epidermal stem cells
Keratinization and exfoliation are natural features of
the epidermis. The epidermis is the tissue that un-
dergoes continuous renewal. The process depends on
the subpopulation of SCs and occurs in the stratum
basale of the epidermis. In a normal epidermis, SCs
constitute approximately 1–10% of the stratum basale.
It is believed that the skin is the human organ tissue
richest in SCs [9].
SCs of the epidermis undergo asymmetric divi-
sions. The effect is self-renewal of epidermal stem
cells (ESCs) and the development of sister cells —
transient amplifying cells (TACs), which undergo
a limited number of mitotic divisions and ultimately
differentiate. The process is very fast in vitro (Figure 1).
It is difficult to distinguish the two types of cells. It
seems identification of CD71 receptor that is ex-
pressed on TACs and is lacking in tissue directed ESCs
may be helpful [30]. Similarly, identification of CD90
antigen is useful to define the keratinocytes popula-
tion that is enriched in SCs [31].
ESCs are not an homogenous population, and dif-
fer with homing site. They may be found in interfolli-
cular parts of the epidermis, in the region of the out-
er root sheath of the hair follicle (bulge), and in the
germinal matrix of the hair follicle [32]. The interfol-
licular SCs closely adhere to the basal lamina of the
epidermis. They resemble somatic SCs. Slow cell cy-
cle of these cells prevents the accumulation of muta-
tions, long life span and proliferation ability provides
maintenance and repair of the tissue they reside. The
final differentiation into keratinocytes begins after loss
of contact with the basement membrane and is relat-
ed to renewal of the epidermis [9].
The hair follicle outer root sheath (bulge) subpop-
ulation of ESCs is a source of keratinocytes and hair
follicle cells. It is the large population of SCs capable
of regenerating a number of skin structures including
the hair follicles and sebaceous glands [2, 14, 33]. Yu
et al. [28] showed in a hair follicle a population of
SCs which express Oct4 and Nanog markers but are
neither ESCs nor melanocyte SCs. These were prob-
ably VSELs. Thus, the epidermis may contain a het-
erogenic population of SCs capable of regenerating
not only the epidermis.
The SCs of the bulge region have a high prolifera-
tion potential. In the epidermis, they remain quies-
cent because of their long cell cycle. In vitro, they
Figure 1. Secondary culture of human keratinocytes
isolated from skin. Two types of colonies formed by
differentiated large cells and by small progenitor epidermal
cells are visualized with a Leica DM IRE2 microscope
equipped with Nomarski interference contrast optics
(own studies)
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maintain their capacity to differentiate. The hair fol-
licle SCs generate ‘daughter’ cells which migrate up
or down the hair follicle. In the upper part of the hair
follicle, they become progenitor cells for the recon-
stitution of the epidermis. In the lower part of the
hair follicle, they change into matrix cells. The inter-
follicular SCs express CD34 marker which is not ex-
pressed by bulge SCs [9, 13–15].
The cells of the bulge region have a higher poten-
tial for regeneration, a longer cell cycle and a higher
clonogenic potential than interfollicular stem cells
whose niche is not clearly defined [9]. Populations of
bulge SCs differentiate into keratinocytes, melano-
cytes, smooth muscles and neurons depending on the
tissue-specific inducing medium. They express embry-
onic markers including Oct4 and Nanog [28].
Culture of epidermal stratum basale cells results
in the formation of clones described as holoclones,
paraclones and meroclones. Holoclones are formed
by SCs and paraclones by TACs. Meroclones contain
a transitional cell type understood to be a reservoir
of TACs. The differentiation of cells occurs from ho-
loclones, through meroclones, to paraclones [32].
ESCs express b1 and a6 integrins, transcription
factor p63 and delta-1, and high expression of cyto-
plasmatic b-catenin with cellular membrane cadherins
and preferentially express the cytokeratins K15 and
K19 [14, 32]. Yu et al. [28] revealed the presence of
cytokeratin K15 in the bulge region and expression
of Nanog and Oct 4 pluripotency markers in the same
localization. This showed that Oct4+ and Nanog+ cells
reside in bulges. The abovementioned cells, when
raised from hair follicles, can be important sources
of autologous SCs for tissue regeneration.
It has been demonstrated that b1 and a6 integrins
are present in the stratum basale cells of the epider-
mis. Migration from this area toward the skin surface
results in a decreased expression of b1 integrin. The
cells with high expression of this integrin are mainly
SCs, which are able to cover for basis of collagen IV
and laminin. Similarly p63, a factor that undergoes
expression in the nucleus, indicates those cells able
to replicate and proliferate. Expression of p63 sharp-
ly decreases during differentiation.
In conclusion, b1 integrin, p63 factor and the oth-
er mentioned factors can be useful as epidermis SCs
high markers. Abundant melanocytes can be removed
from culture by marker c-kit. Additionaly it is possi-
ble to use metabolic dye 123 rhodamine for identifi-
cation of ESCs. Sorting of cells Rh 123 (–) and
b1-integrin (+) enable isolation of enriched SCs frac-
tion forming holoclones in culture [32, 34].
The proliferation of ESCs depends on growth fac-
tors produced by skin fibroblasts including fibroblast
growth factor (FGF-4), keratinocytes growth factor
(KGF), epidermal growth factor (EGF), hepatocyte
growth factor (HGF) and IL-6 and onkostatin M
[9, 14, 15, 32].
Application of epidermal stem cells
ESCs open a new perspective on the healing of dif-
ferent types of skin disorder including severe burns,
chronic leg ulcers, skin cancer, alopecia, and acne
[2, 3, 6, 9, 35].
The epidermis and hair follicle are distinct lineage
compartments maintained by independent SCs pop-
ulations. Both epidermal and follicular keratinocytes
are recruited to participate in epidermal repair in re-
sponse to injury. For instance, in superficial burns with
destroyed interfollicular epidermis and intact hair
follicles, the epidermis is rebuilt because of SCs
present in bulges. It is believed that these cells partic-
ipate only transiently in the initial resurfacing of the
wound and are replaced by SCs from the original epi-
dermal compartment. However, their daughter cells
have been found for months after a wound has healed
[12]. When hair follicles are destroyed due to deep
burns, the epidermis can regrow only via cells migrat-
ing from the edges of intact skin [36].
Skin regeneration in chronic wounds is similar. In
intact skin, cells do not move. They migrate vertically
in the epidermis, being passively pushed by cells grow-
ing at the stratum basale and gradually differentiat-
ing to keratinocytes. In injured skin, they exhibit lat-
eral migration and during wound healing (epithelial)
cells migrate laterally to cover the wound surface [9].
Limat et al. [6] collected and cultured kerati-
nocytes expanded from the outer root sheaths of hair
follicles. Cells were organized in epidermal equiva-
lent prepared from autologous keratinocytes and ap-
plied to the surface of a recurrent leg ulcer. The larg-
er the area of implantation, the faster the re-epithe-
lialization occurred. Within eight weeks, one third of
the ulcers had healed. Patients reported reduced pain
and no side effects of this treatment.
Drukała et al. [3] evaluated the migration of hu-
man keratinocytes from primary and secondary cells
culture on polystyrene, collagen, and fibrin glue. Re-
sults showed furthest displacement on polystyrene,
followed by fibrin glue and collagen, but the fastest
was on the fibrin glue surface. In comparison, these
parameters were much worse when keratinocytes were
organized in sheets. Furthermore, five days after
transplantation of single-cell suspension of autologous
keratinocytes to patients with chronic leg ulcers, the
formation of proliferating cell islands was observed.
In addition, pain was relieved significantly and wound
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secretion was reduced. Results suggest that multifo-
cal skin grafting, as well as the transplantation of sin-
gle-cell suspension, can be very effective treatments
for long-lasting leg ulcers. This effect is absent from
the transplantation of large skin sheets because loco-
motion concerns only edge cells. In addition, in vivo
wound healing that requires fibroblast growth and
collagen synthesis can be stimulated in the presence
of fibrin glue (Figure 2).
Bone marrow SCs and other tissue niches have
been identified as sources of cells which can partici-
pate in the regeneration of injured tissues and organs
[18, 22, 23]. Their mobilization is dependent on the
secretion of tissue factors. The CXCR4-SDF-1 axis
is the most important regulator of migration. It pro-
vides SCs to participate in the rebuilding of damaged
organs thanks to attraction by secreted chemotactic
substances [26].
Bone marrow derivative cells (BMDCs) are not
detected in steady-state epidermal homeostasis. Fan
et al. [37] indicated that in a skin wound-healing
model, the epidermis contains only rare bone mar-
row-derived keratinocytes. This may suggest that
BMDCs are not required for keratinocytes repopu-
lation. Borue et al. [38], unlike above-mentioned
studies, found that skin damage may affect the de-
gree of engraftment of BMDCs to the skin. Proba-
bly, BMDCs do not engraft as ESC, but assist in early
wound healing by engrafting as TACs and differen-
tiate into keratinocytes. Lethal irradiation and re-
constitution of BM indicate engraftment to the
wound skin of transplanted BMDCs. Expression of
Ki 67, a marker for actively cycling cells, correlates
with the increased number of donor-derived cells
within the wound. Donor-derived cytokeratin 5-ex-
pressing cells were rare, suggesting that BMDCs do
not engraft as ESCs, and the level of them peaked
and decreased over time, further suggesting that
BMDCs may assist in early wound healing by en-
grafting as TACs, which then differentiate into ke-
ratinocytes.
According to Inokuma et al. [39], the major regu-
lator of migration of BMDCs into skin is CTACK. It
is constitutively expressed in normal skin and upreg-
ulated in wounds. Furthermore, CD 34+ bone mar-
row cells expressed CCR 10, the ligand for CTACK.
The bone marrow-derived keratinocytes may build
a provisional epidermal layer and later be replaced
by keratinocytes migrating from surrounding skin.
Probably, after injury, BMDCs are recruited by pro-
-inflammatory cytokines. Their homing to the skin is
mediated by CTACK secreted by keratinocytes. In
chronic wounds, the recruitment of BMDCs seems
to be impaired by blocking of CTACK mediated axis.
Inhibition mediated by PSGL-1 released from neu-
trophils present in the inflammatory center may de-
lay the healing of chronic wounds and confirm previ-
ous suggestions about this chemotactic way [40].
Furthermore, direct transplantation of bone mar-
row cells on damaged skin starts their differentiation
into non-hematopoietic skin structures. According to
Krause et al. [5], an enriched population of HSC that
homes to bone marrow can be engrafted to peripher-
al tissues. Thus, rare cells homing to bone marrow
can create a long-term population of SCs with high
differentiation capacity, even into skin cells. The con-
nection of these findings with presence of VSELs in
bone marrow niche should be researched.
Badiavas et al. [1] indicated that direct applica-
tion of autologous bone marrow-derived cells can lead
to closure of non-healing chronic wounds and der-
mal rebuilding. These results suggested engraftment
of applied cells, which was confirmed in biopsy.
Kataoka et al. [4] transplanted mouse bone mar-
row cells onto damaged skin. They observed recon-
stitution of fully differentiated skin within three weeks.
Donor cells were found in the epidermis, hair follicles,
sebaceous glands, and dermis. The localization and
morphology of those cells, immunohistochemistry, and
specific staining confirmed that the bone marrow cells
had differentiated into epidermal keratinocytes, seba-
ceous gland cells and follicular epithelial cells.
Since the SDF-1 — CXCR4 axis has been recog-
nized as an important regulator of trafficking of SCs,
it has become a molecular target for various thera-
peutic interventions. It has been demonstrated that
the expression of CXCR4 could be inhibited at the
transcriptional level by targeting HIF-1a by chetomin,
at the translation level by siRNA or antisense oligode-
oxynucleotides, and at the protein receptor level by
T140 or AMD 3100. Blocking the formation of lipid
rafts in individuals depleted of cholesterol decreases
the responsiveness of cells to an SDF-1 gradient. In-
terestingly, primes of genes coding for receptor
CXCR4 is similar to binding place for HIF-1a. In-
flammation and tissue injury result in chemotactic at-
traction of stem cells for regeneration [25].
The large amount of easily available epidermal stem
cells enriched in early PSCs (with marker Oct-4) rais-
es hopes of a clinical use for treating not only skin
injuries but also for organ regeneration. Our unpub-
lished data showed that burns trigger the mobiliza-
tion of VSELs and progenitor cells expressing early
epidermal markers into the peripheral blood. It is still
too early to determine the potential role of these cells
in skin regeneration. To answer this question, the
optimization of VSELs expansion ex vivo and also
their differentiation into keratinocytes is required.
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The coming years will show if these cells can be used
in regenerative medicine.
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